Keyphrases
Cryptococcal Meningitis
100%
Cerebrospinal Fluid
41%
Meningitis
31%
Uganda
28%
Ugandan
27%
HIV Patients
27%
Antiretroviral Therapy
26%
AIDS/HIV
25%
Cryptococcal Antigen
24%
Amphotericin B
18%
Cryptococcus
18%
Non-HIV Cryptococcal Meningitis
18%
Tuberculous Meningitis
17%
Fluconazole
14%
Resource-limited Settings
10%
Sub-Saharan Africa
10%
Cryptococcal Antigenemia
10%
Xpert MTB
9%
Tuberculosis
9%
Cryptococcosis
9%
Confidence Interval
9%
Meningitis Diagnosis
9%
Immune Reconstitution
8%
Sertraline
8%
HIV-associated
8%
Lateral Flow Assay
7%
Clinical Trials
7%
Co-infection
7%
Cerebrospinal Fluid Culture
6%
Lumbar Puncture
6%
Clinical Outcomes
6%
Diagnostic Performance
6%
Prospective Cohort Study
5%
Amphotericin B Deoxycholate
5%
Referee
5%
CD4 Count
5%
High Mortality
5%
Medicine and Dentistry
Cryptococcal Meningitis
85%
Human Immunodeficiency Virus
71%
Meningitis
32%
Cerebrospinal Fluid
32%
Antiretroviral Therapy
24%
Tuberculous Meningitis
14%
Diagnosis
10%
Amphotericin
9%
Immune Reconstitution Inflammatory Syndrome
8%
Prospective Cohort Study
7%
Lateral Flow Assay
7%
Lumbar Puncture
6%
Mixed Infection
6%
Cryptococcosis
6%
Cerebrospinal Fluid Culture
5%
Prevalence
5%
Biological Marker
5%
Hazard Ratio
5%
Cohort Effect
5%
Diagnostic Performance
5%
Intracranial Pressure
5%